Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

INCB-024360 Epacadostat

Catalog No.
B6036
Orally active indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$61.00
In stock
5mg
$55.00
In stock
25mg
$121.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Epacadostat (CAS 1204669-58-8) is an orally bioavailable small molecule inhibitor, functioning as a potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor in cellular systems and exhibiting strong antagonist activity against IDO1 in various tumor cell types. Additionally, it disrupts tryptophan metabolism and modulates immune cell responses by suppressing kynurenine production.

In preclinical experimental models, Epacadostat reduces IDO1 enzymatic activity with an IC50 value of 71.8 nM, tested against recombinant human IDO1 enzyme as well as in IFN-γ-stimulated cancer cell lines. It can also restore proliferation and cytokine production of T lymphocytes by preventing the accumulation of immunosuppressive metabolites within the tumor microenvironment.

In immuno-oncology research and drug development, Epacadostat is widely used for investigating the role of IDO1-mediated immune evasion in cancer, evaluating novel combinations with PD-1/PD-L1 checkpoint inhibitors, and assessing immune restoration in in vitro and in vivo studies. This compound serves as a valuable tool both for elucidating the mechanisms of tumor immune tolerance and for preclinical screening of potential therapeutic strategies targeting the tumor-immune interface.

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt438.23
Cas No.1204669-58-8
FormulaC11H13BrFN7O4S
SynonymsINCB024360
Solubilityinsoluble in H2O; ≥17.1 mg/mL in DMSO; ≥2.96 mg/mL in EtOH with ultrasonic
Chemical Name(E)-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide
SDFDownload SDF
Canonical SMILESNS(NCCNc1n[o]nc1/C(\NO)=N\c(cc1)cc(Br)c1F)(=O)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Kinase experiment [1]:

Kinase assays

The assays were performed at room temperature using 20 nM IDO and 2 mM D-Trp in the presence of 20 mM ascorbate, 3.5 μM methylene blue and 0.2 mg/mL catalase in 50 mM potassium phosphate buffer (pH 6.5). The initial reaction rates were recorded by continuously following the absorbance increase at 321 nm due to the formation of N’-formlylkynurenine.

Cell experiment [2]:

Cell lines

HeLa cells and human T cells

Preparation method

The solubility of this compound in DMSO is >15.7mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

0.001~2 μM

Applications

IDO1 induction significantly suppressed T-cell proliferation in coculture systems, and the suppression was effectively reversed by INCB024360. IDO1 also increases IFN-γ production, and reduces conversion to regulatory T (Treg)–like cells.

Animal experiment [2]:

Animal models

C57BL/6 mice bearing IDO1-expressing PAN02 pancreatic carcinomas

Dosage form

25 and 100 mg/kg, orally, twice a day for 25 days

Application

The growth of tumors in syngeneic immunocompetent C57BL/6 mice was inhibited in a dose-dependent fashion.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1] Yue EW1, Douty B, Wayland B, et al. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model. Med Chem. 2009 Dec 10;52(23):7364-7.

[2] Liu X, Shin N, Koblish HK, Yang G, Wang Q, Wang K, Leffet L, Hansbury MJ, Thomas B, Rupar M et al: Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood. 2010 Apr 29;115(17):3520-30.

Biological Activity

Description INCB024360 is a potent inhibitor of IDO1 with an IC50 value of 10 nM.
Targets IDO1          
IC50 10 nM          

Quality Control